Ritlecitinib, a promising treatment for alopecia areata, is set to be reviewed by the Scottish Medicines Consortium following its approval for NHS use in England. While it does not cure the condition, it offers an important treatment option for severe cases. Megan McCready, a young woman diagnosed with alopecia at age 12, exemplifies the courage and support that individuals can demonstrate, helping others facing similar challenges. This development marks a significant step forward in providing support to those with alopecia in Scotland.
The drug Ritlecitinib could soon be available for NHS treatment of alopecia areata in Scotland, improving access for many suffering from this common hair loss condition.
While not a cure, Ritlecitinib offers hope for those with severe alopecia areata, including 21-year-old Megan McCready, who has coped with her condition since age 12.
Collection
[
|
...
]